Total Number Of Shares And Voting Rights At September 30, 2025

2025-10-06 12:16:22

(MENAFN- GlobeNewsWire - Nasdaq) 6 October 2025

Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers.

In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.

Date	Number of shares	Number of treasury shares without voting rights	Theoretical number of voting rights [1]	Number of voting rights exercisable
01/31/2025	2,660,056, 599	3,835, 000	3,172,669, 760	3,169,834, 760
02/28/2025	2,660,056, 599	3,055, 955	3,172,495, 644	3,169,439, 689
03/31/2025	2,660,056, 599	3,028, 955	3,173,078, 086	3,170,049, 131
04/30/2025	2,660,056, 599	1,541, 848	3,177,421, 164	3,175,879, 316
05/31/2025	2,660,056, 599	1,676, 848	3,179,973, 369	3,178,296, 521
06/30/2025	2,660,056, 599	1,456, 848	3,180,452, 886	3,178,996, 038
07/31/2025	2,660,056, 599	1,456, 848	3,180,373, 161	3,178,916, 313
08/31/2025	2,660,056, 599	1,504, 348	3,180,273, 144	3,178,768, 796
09/30/2025	2,660,056, 599	1,456, 848	3,180,201, 913	3,178,745, 065

[1] Calculated in accordance with the last paragraph of Article 223-11 of the General Regulations, on the basis of all the shares to which voting rights are attached, including shares without voting rights.

Attachment

20250930_Information on number of shares and voting rights

MENAFN06102025004107003653ID1110157031

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.